As the FDA went about the critical work of evaluating the safety of COVID-19 vaccines, the agency tapped Optum Scientific Consulting, with a 25-year history of evaluating drugs and vaccines. In this episode, Optum's Chief Scientific Officer John Seeger explains: 

• Optum Scientific Consulting's history of evaluating drugs and vaccines.
• The group's partnership with the FDA to evaluate COVID-19 vaccines for kids ages 5 to 11. 
• The broader impact and promise of data on drug and vaccine safety.